Evaluation of machine learning models for cytochrome P450 3A4, 2D6, and 2C9 inhibition

被引:0
|
作者
Gong, Changda [1 ]
Feng, Yanjun [1 ]
Zhu, Jieyu [1 ]
Liu, Guixia [1 ]
Tang, Yun [1 ]
Li, Weihua [1 ,2 ]
机构
[1] East China Univ Sci & Technol, Shanghai Frontiers Sci Ctr Optogenet Tech Cell Met, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai, Peoples R China
[2] East China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai Frontiers Sci Ctr Optogenet Tech Cell Met, 130 Meilong Rd, Shanghai 200237, Peoples R China
关键词
cytochrome P450 inhibition; in silico prediction; machine learning; model comparison; CLASSIFICATION;
D O I
10.1002/jat.4601
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Cytochrome P450 (CYP) enzymes are involved in the metabolism of approximately 75% of marketed drugs. Inhibition of the major drug-metabolizing P450s could alter drug metabolism and lead to undesirable drug-drug interactions. Therefore, it is of great significance to explore the inhibition of P450s in drug discovery. Currently, machine learning including deep learning algorithms has been widely used for constructing in silico models for the prediction of P450 inhibition. These models exhibited varying predictive performance depending on the use of machine learning algorithms and molecular representations. This leads to the difficulty in the selection of appropriate models for practical use. In this study, we systematically evaluated the conventional machine learning and deep learning models for three major P450 enzymes, CYP3A4, CYP2D6, and CYP2C9 from several perspectives, such as algorithms, molecular representation, and data partitioning strategies. Our results showed that the XGBoost and CatBoost algorithms coupled with the combined fingerprint/physicochemical descriptor features exhibited the best performance with Area Under Curve (AUC) of 0.92, while the deep learning models were generally inferior to the conventional machine learning models (average AUC reached 0.89) on the same test sets. We also found that data volume and sampling strategy had a minor effect on model performance. We anticipate that these results are helpful for the selection of molecular representations and machine learning/deep learning algorithms in the P450 model construction and the future model development of P450 inhibition. Inhibition of the major drug-metabolizing cytochrome P450 enzymes could lead to serious adverse reactions. Currently, a variety of machine learning models have been developed for the prediction of P450 inhibitors, but a detailed comparison is lacking. Different algorithms and representations were used to build the predictive models, and their performance was compared here.
引用
收藏
页码:1050 / 1066
页数:17
相关论文
共 50 条
  • [1] Inhibition models for cytochrome P450 1A2, 2C9, 2D6, and 3A4
    Zhuang, Dechuan
    Zhang, Jinhua
    Fraczkiewicz, Robert
    Bolger, Michael B.
    Waldman, Marvin
    Woltosz, Walter S.
    Enslein, Kurt
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [2] Empirical regioselectivity models for human cytochromes p450 3A4, 2D6, and 2C9
    Sheridan, Robert P.
    Korzekwa, Kenneth R.
    Torres, Rhonda A.
    Walker, Matthew J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (14) : 3173 - 3184
  • [3] Predicting Drug Metabolism by Cytochrome P450 2C9: Comparison with the 2D6 and 3A4 Isoforms
    Rydberg, Patrik
    Olsen, Lars
    CHEMMEDCHEM, 2012, 7 (07) : 1202 - 1209
  • [4] Ligand-based models for the isoform specificity of cytochrome P450 3A4, 2D6, and 2C9 substrates
    Terfloth, Lothar
    Bienfait, Bruno
    Gasteiger, Johann
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2007, 47 (04) : 1688 - 1701
  • [5] Generation of in-silico cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A4 inhibition QSAR models
    Gleeson, M. Paul
    Davis, Andrew M.
    Chohan, Kamaldeep K.
    Paine, Stuart W.
    Boyer, Scott
    Gavaghan, Claire L.
    Arnby, Catrin Hasselgren
    Kankkonen, Cecilia
    Albertson, Nan
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2007, 21 (10-11) : 559 - 573
  • [6] Generation of in-silico cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A4 inhibition QSAR models
    M. Paul Gleeson
    Andrew M. Davis
    Kamaldeep K. Chohan
    Stuart W. Paine
    Scott Boyer
    Claire L. Gavaghan
    Catrin Hasselgren Arnby
    Cecilia Kankkonen
    Nan Albertson
    Journal of Computer-Aided Molecular Design, 2007, 21 : 559 - 573
  • [7] IDENTIFICATION OF CYTOCHROME P450 2D6, 2C9 AND 3A4 SUBSTRATES AND INHIBITORS BY QSAR MODELS BASED ON HUMAN CLINICAL DATA
    Jonsdottir, Svava O.
    Ringsted, Tine
    Nikolov, Nikolai G.
    Dybdahl, Marianne
    Wedebye, Eva B.
    Niemela, Jay R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 (01) : 156 - 156
  • [8] Prediction of cytochrome p450 3A4, 2D6, and 2C9 inhibitors and substrates by using support vector machines
    Yap, CW
    Chen, YZ
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2005, 45 (04) : 982 - 992
  • [9] The 4-hydroxylation of tamoxifen by human liver cytochromes P450 2D6, 2C9 and 3A4
    Lennard, MS
    Crewe, HK
    Ellis, SW
    Tucker, GT
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PI37 - PI37
  • [10] Effect of eugenol on cytochrome P450 1A2, 2C9, 2D6, and 3A4 activity in human liver microsomes
    Alharbi, Naif Fahad M.
    Ahad, Abdul
    Bin Jardan, Yousef A.
    Al-Jenoobi, Fahad I.
    SAUDI PHARMACEUTICAL JOURNAL, 2024, 32 (07)